Ultrasound Wirelessly Controlled Electrically Responsive Implantable Drug Delivery System for Enhanced Tumor Therapy
Small · 2025
DOI: 10.1002/smll.202412704 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2025. Verfasst von Haimei Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics Trauma and Microsurgery, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan,…. Hauptthemen laut MEDLINE: Drug Delivery Systems, Wireless Technology, Neoplasms, Ultrasonic Waves. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Large-Scale Instrument and Equipment Sharing Foundation of Wuhan University.
Abstract (Originalsprache)
Implantable controlled local drug delivery offers many advantages over systemic delivery. However, wirelessly controlling drug release from implanted devices via exogenous stimulation remains challenging. Herein, an ultrasound wirelessly controlled electrically responsive implantable drug delivery system (UI‐TENG‐IDDS) is proposed, which consists of an ultrasound‐driven implantable triboelectric nanogenerator (UI‐TENG) and an electrically responsive drug reservoir. When ultrasound is applied to the skin, it induces high‐frequency vibrations in the UI‐TENG, generating pulsed electrical output (≈50 µA at 9 V) to electrolyze water, thereby increasing the alkalinity near the cathode and dissolving drug carrier (co‐PMMA) to release drugs. Moreover, UI‐TENG‐IDDS can accelerate the diffusion of negatively charged drugs via iontophoresis mechanism. Methotrexate (MTX) loaded UI‐TENG‐IDDS has been applied to ablate tumors without causing evident side effects. The UI‐TENG‐IDDS can wirelessly control drug release without complex electronic design and the electrical outputs are not limited by the battery life and capacity, avoiding battery replacement surgery. Considering the advantage that TENG can be fabricated using biodegradable and biocompatible materials, this work provides an efficient, economical, and safe regimen for spatiotemporal controlled implantable drug delivery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics Trauma and Microsurgery, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan, 430071, China.
- Key Laboratory of Combinatorial Biosynthesis and Drug Discovery (MOE), Wuhan University, Wuhan, 430072, China.
- National Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074, China.
ORCID-Profile: Peng Jiang
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Large-Scale Instrument and Equipment Sharing Foundation of Wuhan University
- National Postdoctoral Program for Innovative Talents
Zitieren
APA
Li, H., He, G., Hu, Y., Li, X., Hu, J., & Jiang, P. (2025). Ultrasound Wirelessly Controlled Electrically Responsive Implantable Drug Delivery System for Enhanced Tumor Therapy. Small. https://doi.org/10.1002/smll.202412704
Vancouver
Li H, He G, Hu Y, Li X, Hu J, Jiang P. Ultrasound Wirelessly Controlled Electrically Responsive Implantable Drug Delivery System for Enhanced Tumor Therapy. Small. 2025. doi:10.1002/smll.202412704
BibTeX
@article{Li2025,
author = {Li, Haimei and He, Guangqin and Hu, Yulin and Li, Xuyu and Hu, Jun and Jiang, Peng},
title = {Ultrasound Wirelessly Controlled Electrically Responsive Implantable Drug Delivery System for Enhanced Tumor Therapy},
journal = {Small},
year = {2025},
doi = {10.1002/smll.202412704}
}
EUVIMED